Skip to main content
< Back
About
About the conference
Latest updates
Organisers & Partners
App
Press room
Programme 19
Full programme
Tracks
Speakers 19
Keynote speakers
All speakers
Side events 19
Venue 19
About the venue
Location
Rooms
Subscribe
Psychedelics
Sessions
Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour
Health consequences
Wednesday, 23 October
15:00
New psychoactive substances
15:00
to
16:30
Networking zone 3 (N3)
Pierluigi Simonato
Therapeutic horizons I
15:00
to
16:30
Networking zone 1 (N1)
Wouter Vanderplasschen
Presentations
Plenary session
Poster session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
Poster guided tour
Wednesday, 23 October
15:10
Short communication
Insights into benzo fury toxicity: 5-(2-aminopropyl)benzofuran and 6-(2-aminopropyl)benzofuran disrupt oxidative, energetic and mitochondrial homeostasis of hepatocytes in vitro
15:10
to
15:20
Networking zone 3 (N3)
Rita Roque Bravo
Oral presentation
A peer-led integrated approach for co-existing mental and addictive disorders: a longitudinal qualitative study of the first UK dual diagnosis anonymous
15:10
to
15:25
Networking zone 1 (N1)
Raffaella Margherita Milani
15:20
Short communication
Tracking NPS in Portugal: the case of MTMP
15:20
to
15:30
Networking zone 3 (N3)
Helena Gaspar
15:25
Oral presentation
m-Health among illicit drug users: effectiveness, differential indication, risks and negative effects and ongoing developments among guided and unguided interventions
15:25
to
15:40
Networking zone 1 (N1)
Michael Schaub
15:30
Short communication
Single binge dosing of 4-Methylethcathinone (4-MEC) induces sturdy and durable cognitive impairment in mice
15:30
to
15:40
Networking zone 3 (N3)
Cristina Sampayo
15:40
Short communication
Abuse potential of new psychoactive substances: N-ethylhexedrone, 4-Methylethcathinone, 4-Fluoromethcathinone and Buphedrone
15:40
to
15:50
Networking zone 3 (N3)
Cristina Sampayo
Oral presentation
Associations of ketamine use with mental health and substance use outcomes at 12 months follow-up in young Europeans
15:40
to
15:55
Networking zone 1 (N1)
Meryem Grabski
15:50
Short communication
Studies on the metabolism of synthetic cathinones N-ethylhexedrone and buphedrone using liquid chromatography-mass spectrometry (LC-MS/MS)
15:50
to
16:00
Networking zone 3 (N3)
Joana Carrola
15:55
Oral presentation
The acceptability of psychedelics as treatment options in psychiatry. Data from GDS2019
15:55
to
16:10
Networking zone 1 (N1)
Adam Winstock
16:00
Short communication
Changa – fist time identification in Portugal
16:00
to
16:10
Networking zone 3 (N3)
Maria João Caldeira
16:10
Short communication
Variations and determinants of novel psychoactive substance use: a mixed methods study to identify the implications for policy and practice
16:10
to
16:20
Networking zone 3 (N3)
Kathryn Higgins
Oral presentation
Effectiveness and cost-effectiveness of adjunctive personalised psychosocial intervention in treatment-resistant maintenance opioid agonist therapy: a pragmatic, open-label, randomised controlled trial
16:10
to
16:25
Networking zone 1 (N1)
John Marsden